{"transactions":[{"id":755483,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:16:41.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001134365-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000113436526000001/primarydocument.xml","form_type":"4"}},{"id":755482,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:16:41.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001134365-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000113436526000001/primarydocument.xml","form_type":"4"}},{"id":1125705,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:32:14.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004350","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218025004350/primarydocument.xml","form_type":"4"}},{"id":1125704,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:32:14.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004350","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218025004350/primarydocument.xml","form_type":"4"}},{"id":1180489,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T20:39:53.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":7600,"derivative":{"exercise_price":15.2,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":7600},"source":{"system":"sec-edgar","filing":"0001764013-25-000041","document":"wk-form4_1743712786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401325000041/wk-form4_1743712786.xml","form_type":"4"}},{"id":1180488,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:39:53.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":16188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":137251,"source":{"system":"sec-edgar","filing":"0001764013-25-000041","document":"wk-form4_1743712786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401325000041/wk-form4_1743712786.xml","form_type":"4"}},{"id":1493058,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-04T20:43:28.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":24454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer."}],"balance_after":24454,"derivative":{"exercise_price":14.35,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":24454},"source":{"system":"sec-edgar","filing":"0001562180-24-004655","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218024004655/primarydocument.xml","form_type":"4"}},{"id":1493057,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:43:28.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-004655","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218024004655/primarydocument.xml","form_type":"4"}},{"id":1548017,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-04T20:48:19.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":4690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest on April 2, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":4690,"derivative":{"exercise_price":30.78,"expiration_date":"2034-04-02","underlying":"Common Stock","underlying_shares":4690},"source":{"system":"sec-edgar","filing":"0001764013-24-000063","document":"wk-form4_1712263688.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401324000063/wk-form4_1712263688.xml","form_type":"4"}},{"id":1548016,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:48:19.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":11255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 2, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":121063,"source":{"system":"sec-edgar","filing":"0001764013-24-000063","document":"wk-form4_1712263688.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401324000063/wk-form4_1712263688.xml","form_type":"4"}},{"id":1722329,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T21:25:33.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":5022,"price":40.46,"value":203190.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.20 - $40.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":109808,"source":{"system":"sec-edgar","filing":"0001764013-23-000153","document":"wk-form4_1701811523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401323000153/wk-form4_1701811523.xml","form_type":"4"}},{"id":1722328,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T21:25:33.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":3478,"price":39.81,"value":138459.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.20 - $40.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":114830,"source":{"system":"sec-edgar","filing":"0001764013-23-000153","document":"wk-form4_1701811523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401323000153/wk-form4_1701811523.xml","form_type":"4"}},{"id":1722327,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-05T21:25:33.000Z","date":"2023-12-01","kind":"sale","planned":true,"acquired":false,"shares":4200,"price":38.79,"value":162918.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.20 - $39.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":118308,"source":{"system":"sec-edgar","filing":"0001764013-23-000153","document":"wk-form4_1701811523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401323000153/wk-form4_1701811523.xml","form_type":"4"}},{"id":1865499,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-06T21:12:30.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":17892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer."}],"balance_after":17892,"derivative":{"exercise_price":19.72,"expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":17892},"source":{"system":"sec-edgar","filing":"0001562180-23-004892","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218023004892/primarydocument.xml","form_type":"4"}},{"id":1865498,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:12:30.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer."}],"balance_after":6496,"source":{"system":"sec-edgar","filing":"0001562180-23-004892","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218023004892/primarydocument.xml","form_type":"4"}},{"id":1919768,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-14T20:31:17.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":16260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":16260,"derivative":{"exercise_price":14.7,"expiration_date":"2033-04-12","underlying":"Common Stock","underlying_shares":16260},"source":{"system":"sec-edgar","filing":"0001764013-23-000044","document":"wf-form4_168150426702734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401323000044/wf-form4_168150426702734.xml","form_type":"4"}},{"id":1919767,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T20:31:17.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":12523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":122508,"source":{"system":"sec-edgar","filing":"0001764013-23-000044","document":"wf-form4_168150426702734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401323000044/wf-form4_168150426702734.xml","form_type":"4"}},{"id":2178519,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-19T20:44:04.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":31668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":31668,"derivative":{"exercise_price":4.99,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":31668},"source":{"system":"sec-edgar","filing":"0001764013-22-000093","document":"wf-form4_166094182912795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401322000093/wf-form4_166094182912795.xml","form_type":"4"}},{"id":2178518,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-19T20:44:04.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":21059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":109985,"source":{"system":"sec-edgar","filing":"0001764013-22-000093","document":"wf-form4_166094182912795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401322000093/wf-form4_166094182912795.xml","form_type":"4"}},{"id":2240550,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T20:21:01.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer."}],"balance_after":15324,"derivative":{"exercise_price":22.84,"expiration_date":"2032-06-03","underlying":"Common Stock","underlying_shares":15324},"source":{"system":"sec-edgar","filing":"0001562180-22-004879","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218022004879/primarydocument.xml","form_type":"4"}},{"id":2240549,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:21:01.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":3010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer."}],"balance_after":3010,"source":{"system":"sec-edgar","filing":"0001562180-22-004879","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218022004879/primarydocument.xml","form_type":"4"}},{"id":2437047,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-12T22:03:48.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":71492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":131792,"derivative":{"exercise_price":7.94,"expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":71492},"source":{"system":"sec-edgar","filing":"0001764013-22-000019","document":"wf-form4_164202501508435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401322000019/wf-form4_164202501508435.xml","form_type":"4"}},{"id":2437046,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-12T22:03:48.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":21726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":88926,"source":{"system":"sec-edgar","filing":"0001764013-22-000019","document":"wf-form4_164202501508435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401322000019/wf-form4_164202501508435.xml","form_type":"4"}},{"id":2576253,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-08T20:24:36.000Z","date":"2021-09-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over the 36 months following September 3, 2021, with immediate full vesting in the event of a change in control."}],"balance_after":20000,"derivative":{"exercise_price":34.98,"expiration_date":"2031-09-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-21-005879","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000156218021005879/primarydocument.xml","form_type":"4"}},{"id":2595235,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T22:14:10.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":7000,"price":7.65,"value":53550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 - $7.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":67200,"source":{"system":"sec-edgar","filing":"0001764013-21-000090","document":"wf-form4_162949763817516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401321000090/wf-form4_162949763817516.xml","form_type":"4"}},{"id":2775184,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-23T12:58:51.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":23300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the options vest one year after the date of grant on March 19, 2022, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":23300,"derivative":{"exercise_price":17,"expiration_date":"2031-03-19","underlying":"Common Stock","underlying_shares":23300},"source":{"system":"sec-edgar","filing":"0001764013-21-000045","document":"wf-form4_161650431840974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401321000045/wf-form4_161650431840974.xml","form_type":"4"}},{"id":2775183,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-23T12:58:51.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock unit awards (\"RSUs\") granted to the Reporting Person pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in their entirety one year after the date of grant on March 19, 2022, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"20,000 shares are the result of a pro rata distribution from Health Sciences Holdings, LLC, of which the Reporting Person was a member of Health Sciences Acquisition Corporation's board of directors."}],"balance_after":60200,"source":{"system":"sec-edgar","filing":"0001764013-21-000045","document":"wf-form4_161650431840974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000176401321000045/wf-form4_161650431840974.xml","form_type":"4"}},{"id":3104821,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-19T20:15:22.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":45566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on December 17, 2020."}],"balance_after":45566,"derivative":{"exercise_price":3.03,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":45566},"source":{"system":"sec-edgar","filing":"0001493152-20-011509","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220011509/ownership.xml","form_type":"4"}},{"id":3104820,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-19T20:15:22.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":37954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on December 17, 2020."}],"balance_after":37954,"source":{"system":"sec-edgar","filing":"0001493152-20-011509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220011509/ownership.xml","form_type":"4"}},{"id":3145842,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-18T12:52:17.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest in eight equal quarterly installments measured from May 15, 2020, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":37000,"derivative":{"exercise_price":19.01,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001209191-20-029944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000120919120029944/doc4.xml","form_type":"4"}},{"id":3145841,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T12:52:17.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":24700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\") pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in two equal annual installments on May 15, 2021 and May 15, 2022, subject to the Reporting Person's continued service to the Issuer as of each such date; provided that each director may elect to defer settlement of the RSUs upon vesting, subject to Rule 409A regulation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\") pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in two equal annual installments on May 15, 2021 and May 15, 2022, subject to the Reporting Person's continued service to the Issuer as of each such date; provided that each director may elect to defer settlement of the RSUs upon vesting, subject to Rule 409A regulation."}],"balance_after":24700,"source":{"system":"sec-edgar","filing":"0001209191-20-029944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000120919120029944/doc4.xml","form_type":"4"}},{"id":4170313,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:09:38.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":17000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These options, which vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board, were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, which vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board, were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-059630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000120919117059630/doc4.xml","form_type":"4"}},{"id":4170312,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:09:38.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":32069,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.08,"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":32069},"source":{"system":"sec-edgar","filing":"0001209191-17-059630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000120919117059630/doc4.xml","form_type":"4"}},{"id":4170311,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:09:38.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":55772,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option, which vests in equal monthly installments over 48 months beginning June 3, 2015, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger dated October 2, 2017 between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option, which vests in equal monthly installments over 48 months beginning June 3, 2015, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger dated October 2, 2017 between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."}],"balance_after":0,"derivative":{"exercise_price":4.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":55772},"source":{"system":"sec-edgar","filing":"0001209191-17-059630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000120919117059630/doc4.xml","form_type":"4"}},{"id":4303210,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":42508,"kind":"person","name":"MIGAUSKY GEORGE V","position":1,"cik":"0001134365","reported_name":"MIGAUSKY GEORGE V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T20:47:09.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board."}],"balance_after":17000,"derivative":{"exercise_price":1.15,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-035881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1134365/000120919117035881/doc4.xml","form_type":"4"}}]}